News | Pulmonary Embolism

Results from the MERCURY PE study showed that low-risk pulmonary embolism (PE) patients treated with Xarelto (rivaroxaban) and discharged early from the emergency department had significantly reduced time in the hospital and a median savings of $2,496 per patient. MERCURY PE results were published in Academic Emergency Medicine.

Home June 29, 2018
Home
News | Pacemakers

Investigators at Children's Hospital Los Angeles (CHLA) and the University of Southern California (USC) have demonstrated the feasibility of implanting a micropacemaker system in the pericardial sac surrounding the heart. The development represents a breakthrough that may open up new cardiac pacing options for children and adults.

Home June 29, 2018
Home
Technology | Interventional Radiology

Embolx Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its next-generation family of Sniper Balloon Occlusion Microcatheters for pressure-directed arterial embolization therapy. Now commercially available in the United States, the next-generation family of Sniper devices offers physicians enhanced performance features to improve access and allow easy navigation through small complex vascular structures.

Home June 29, 2018
Home
Videos | Cardiovascular Ultrasound

Sunil Mankad, M.D., FASE, ASE 2018 meeting program chair and director of transesophageal echocardiography at Mayo Clinic ...

Home June 28, 2018
Home
Videos | Cardiovascular Ultrasound

This is a demonstration of the the Philips TrueVue photo-realistic rendering and lighting source technology. This ...

Home June 28, 2018
Home
Technology | Teleradiology

Dictum Health Inc., creators of the Virtual Exam Room (VER) telehealth technology, announced the release of their Care Central advanced telestroke module. The module provides neurological images viewing capability for use with the VER to reduce door-to-needle time, improve patient outcomes and lower costs.

Home June 28, 2018
Home
News | Cardiovascular Ultrasound

A recent study conducted with the Minneapolis Heart Institute found that Bay Labs’ EchoMD AutoEF deep learning software has less variability in evaluating left ventricular ejection fraction (EF) than the average variability of cardiologists reported in literature. Results of the study were presented at the 2018 American Society of Echocardiography (ASE) Annual Scientific Sessions, June 22-26 in Nashville.

Home June 27, 2018
Home
News | Defibrillator Monitors

June 27, 2018 — Wearable cardioverter defibrillators may be a safe and effective alternative to surgically implanted ...

Home June 27, 2018
Home
News | Antiplatelet and Anticoagulation Therapies

Results from a 902-person, five-country survey of people living with atrial fibrillation (AF) reinforce the importance of patient-physician discussion around the reversal of blood thinning (anticoagulant) treatments in potential emergency situations.

Home June 27, 2018
Home
News | Left Atrial Appendage (LAA) Occluders

MedStar Heart & Vascular Institute physicians participating in a clinical trial have become the first in the Mid-Atlantic region to implant the Watchman FLX device. The Watchman FLX is the next generation of a potentially life-changing device proven to reduce the risk of stroke in certain patients with atrial fibrillation (AFib).

Home June 26, 2018
Home
News | Artificial Intelligence

Northwestern Medicine Bluhm Cardiovascular Institute in Illinois received a $25 million gift from the Bluhm Family Charitable Foundation, formed by Neil G. Bluhm, a prominent Chicago philanthropist and real estate developer. The gift will fund, in part, a first-of-its-kind center that utilizes artificial intelligence (AI) and machine learning to advance the study and treatment of cardiovascular disease.Northwestern Medicine Bluhm Cardiovascular Institute in Illinois received a $25 million gift from the Bluhm Family Charitable Foundation, formed by Neil G. Bluhm, a prominent Chicago philanthropist and real estate developer. The gift will fund, in part, a first-of-its-kind center that utilizes artificial intelligence (AI) and machine learning to advance the study and treatment of cardiovascular disease.

Home June 26, 2018
Home
News | Heart Failure

New research finds changes in cellular struts called microtubules (MT) can affect the stiffness of diseased human heart muscle cells. Furthermore, reversing these modifications can lessen the stiffness and improve the beating strength of these cells isolated from transplant patients with heart failure, found researchers from the Perelman School of Medicine at the University of Pennsylvania. This Nature Medicine new study is a continuation of research conducted two years ago on how MTs are involved in regulating the heartbeat.

Home June 25, 2018
Home
News | Cardiovascular Information Systems (CVIS)

Digisonics will exhibit its latest functionality for data-driven decisions at the American Society of Echocardiography 29th Annual Scientific Sessions, June 22-26 in Nashville, Tenn.

Home June 25, 2018
Home
News | CT Angiography (CTA)

Computed tomography (CT) angiography is a useful adjunct to autopsy that is likely to increase the quality of post-mortem diagnosis, according to a study appearing online in the journal Radiology. Researchers said the findings could have important implications for criminal investigations and hospital quality control efforts.

Home June 25, 2018
Home
New echo technology and products at the 2018 ASE meeting.
Feature | ASE

More than 60 companies and organizations are displaying their latest products and services at the 2018 American Society ...

Home June 22, 2018
Home
Subscribe Now